EUDA Health Enters Second Amendment To Warrant Agreement With Streeterville To Further Reduce Exercise Price From $4/Share To $2/Share

Under the terms of the Second Warrant Amendment dated January 13, 2026, the Company and Streeterville Capital agreed to further reduce the exercise price of the warrant from US$4.00 per share to US$2.00 per share. In addition, the minimum closing price of the Company's ordinary shares required to trigger a forced exercise under the warrant was reduced from US$6.00 to US$3.00. All other terms of the warrant remain unchanged.